Physician profile
Thomas Xu
NPI 1063766160
$6,542.17
in general payments reported to CMS, 2019-2025
21 companies · $455 in 2025
The $455 reported for 2025 was more than what a typical Pain Medicine (Physical Medicine & Rehabilitation) provider received nationally (typical 2025 total: $400).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,984 · 2020: $1,097 · 2021: $439 · 2022: $840 · 2023: $425 · 2024: $302 · 2025: $455.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $976 · Travel and Lodging: $206.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $976.08 |
| Travel and Lodging | $205.78 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Nevro Corp. | $4,377.84 | 2019-2024 | Senza |
| Boston Scientific Corporation | $517.30 | 2019-2023 | Wavewriter Alpha Prime 16 |
| Intuitive Surgical, INC. | $205.78 | 2025 | |
| Azurity Pharmaceuticals, INC. | $205.44 | 2023-2025 | Horizant, Horizant |
| Arbor Pharmaceuticals, INC. | $189.18 | 2021-2022 | |
| Abbott Laboratories | $176.26 | 2019-2025 | Proclaim |
| Avanos Medical | $162.68 | 2023-2025 | Coolief* Cooled Radiofrequency, Coolief Cooled Radiofrequency |
| Integra Lifesciences Corporation | $141.51 | 2019 | |
| Abbvie INC. | $105.08 | 2024-2025 | |
| Kerecis Limited | $94.48 | 2020 | |
| Ucb, INC. | $78.89 | 2019-2020 | |
| Assertio Therapeutics, INC. | $50.35 | 2019-2020 | |
| Nalu Medical, INC. | $44.75 | 2024 | Nalu Neurostimulation System |
| Merit Medical Systems INC | $35.38 | 2020 | |
| Genzyme Corporation | $30.22 | 2019 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Curonix LLC | $28.94 | 2025 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Spr Therapeutics, INC | $23.50 | 2020 | |
| Biotronik Nro, INC. | $23.32 | 2024 | Prospera |
| Amgen INC. | $19.45 | 2021 | |
| Biogen, INC. | $17.95 | 2021 | |
| Greenwich Biosciences, INC. | $13.87 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Thomas Xu listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.